Edap Tms (NASDAQ:EDAP – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a report released on Tuesday.
Separately, HC Wainwright restated a “buy” rating and set a $19.00 price target on shares of Edap Tms in a research note on Friday, May 17th.
View Our Latest Report on EDAP
Edap Tms Stock Up 1.5 %
Edap Tms (NASDAQ:EDAP – Get Free Report) last issued its quarterly earnings results on Thursday, May 16th. The medical equipment provider reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). Edap Tms had a negative return on equity of 31.44% and a negative net margin of 30.12%. The business had revenue of $16.13 million for the quarter, compared to analysts’ expectations of $16.22 million. Analysts predict that Edap Tms will post -0.51 EPS for the current fiscal year.
Institutional Investors Weigh In On Edap Tms
Institutional investors and hedge funds have recently modified their holdings of the company. Virtu Financial LLC acquired a new stake in shares of Edap Tms during the first quarter worth about $82,000. Miracle Mile Advisors LLC acquired a new stake in shares of Edap Tms during the 1st quarter worth approximately $136,000. Roubaix Capital LLC purchased a new position in shares of Edap Tms during the 1st quarter valued at approximately $169,000. Finally, Rock Springs Capital Management LP lifted its stake in shares of Edap Tms by 14.6% in the 3rd quarter. Rock Springs Capital Management LP now owns 1,360,000 shares of the medical equipment provider’s stock valued at $9,547,000 after purchasing an additional 173,700 shares during the period. Institutional investors and hedge funds own 62.74% of the company’s stock.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
See Also
- Five stocks we like better than Edap Tms
- 5 discounted opportunities for dividend growth investors
- RXO Shares Surge Following New Acquisition Deal
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- How to Evaluate a Stock Before BuyingÂ
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.